Thomas Berger

3.9k total citations · 1 hit paper
30 papers, 3.0k citations indexed

About

Thomas Berger is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Thomas Berger has authored 30 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Thomas Berger's work include Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (13 papers) and CAR-T cell therapy research (8 papers). Thomas Berger is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (13 papers) and CAR-T cell therapy research (8 papers). Thomas Berger collaborates with scholars based in Germany, United States and Austria. Thomas Berger's co-authors include Gerold Schuler, Detlef Dieckmann, Susanne Berchtold, Beatrice Schuler‐Thurner, Erwin Schultz, Susanne Ebner, Nikolaus Romani, Georg Weinlich, Peter Fritsch and Armin Bender and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Thomas Berger

28 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood

2001 935 citations Susanne Berchtold, Thomas Berger et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Berger Germany	20	2.4k	944	752	196	196	30	3.0k
Shinsuke Taki Japan	28	2.7k 1.1×	916 1.0×	800 1.1×	227 1.2×	237 1.2×	64	3.5k
Danita H. Schuurhuis Netherlands	26	1.9k 0.8×	928 1.0×	888 1.2×	231 1.2×	168 0.9×	36	2.8k
Alina C. Boesteanu United States	24	3.2k 1.3×	749 0.8×	556 0.7×	270 1.4×	241 1.2×	35	3.9k
Jernej Godec United States	17	2.4k 1.0×	1.6k 1.6×	912 1.2×	257 1.3×	173 0.9×	19	3.4k
Takanori So Japan	30	2.0k 0.8×	791 0.8×	753 1.0×	170 0.9×	196 1.0×	78	3.0k
Dennis M. Willerford United States	21	1.8k 0.7×	609 0.6×	842 1.1×	178 0.9×	239 1.2×	28	2.8k
Wataru Ise Japan	23	3.0k 1.2×	533 0.6×	760 1.0×	275 1.4×	209 1.1×	41	3.8k
Saskia J. Santegoets Netherlands	31	2.3k 1.0×	1.9k 2.0×	720 1.0×	248 1.3×	178 0.9×	73	3.2k
James P. Lodolce United States	14	2.4k 1.0×	545 0.6×	784 1.0×	391 2.0×	192 1.0×	20	3.1k
Kristin L. Komschlies United States	24	1.5k 0.6×	674 0.7×	480 0.6×	201 1.0×	164 0.8×	38	2.1k

Countries citing papers authored by Thomas Berger

Since Specialization

Citations

This map shows the geographic impact of Thomas Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Berger more than expected).

Fields of papers citing papers by Thomas Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Berger. The network helps show where Thomas Berger may publish in the future.

Co-authorship network of co-authors of Thomas Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Berger. A scholar is included among the top collaborators of Thomas Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Berger. Thomas Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berger, Thomas, et al.. (2025). Sequential factor delivery enables efficient workflow for universal gene editing in clinical grade iPS cells. Scientific Reports. 15(1). 32514–32514.

Wilke, Benjamin K., et al.. (2025). Validity and Reliability of Teleconference-Based Goniometry for Measuring Ankle and Great Toe Joint Range of Motion. Cureus. 17(4). e81964–e81964.

Gredler, Viktoria, Susanne Ebner, Kathrin Schanda, et al.. (2009). Impact of human myelin on the maturation and function of human monocyte-derived dendritic cells. Clinical Immunology. 134(3). 296–304. 9 indexed citations

Al‐Salam, Suhail, Norbert Nowotny, M. Rizwan Sohail, Jolanta Kolodziejek, & Thomas Berger. (2008). Ecthyma contagiosum (orf) – report of a human case from the United Arab Emirates and review of the literature. Journal of Cutaneous Pathology. 35(6). 603–607. 29 indexed citations

Rößner, Susanne, Alexander H. Dalpke, Konrad A. Bode, et al.. (2007). TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. Molecular Immunology. 45(1). 244–252. 54 indexed citations

Berger, Thomas, Erwin Strasser, Richard J. Smith, et al.. (2005). Efficient elutriation of monocytes within a closed system (Elutra™) for clinical-scale generation of dendritic cells. Journal of Immunological Methods. 298(1-2). 61–72. 87 indexed citations

Berger, Thomas, Eggert Stockfleth, Thomas F. Meyer, Franklin Kiesewetter, & Jens Oliver Funk. (2005). Multiple disseminated large-cell acanthomas of the skin associated with human papillomavirus type 6. Journal of the American Academy of Dermatology. 53(2). 335–337. 8 indexed citations

Maczek, Christian, Thomas Berger, Beatrice Schuler‐Thurner, et al.. (2005). Differences in phenotype and function between spontaneously occurring melan‐A‐, tyrosinase‐ and influenza matrix peptide‐specific CTL in HLA‐A*0201 melanoma patients. International Journal of Cancer. 115(3). 450–455. 15 indexed citations

Schultz, Erwin, Beatrice Schuler‐Thurner, Vincent Stroobant, et al.. (2004). Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy. The Journal of Immunology. 172(2). 1304–1310. 54 indexed citations

10.

Berger, Thomas, Ina Haendle, David Schrama, et al.. (2004). Circulation and homing of melanoma‐reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte‐derived dendritic cells. International Journal of Cancer. 111(2). 229–237. 33 indexed citations

11.

Ju, Xinsheng, Christine Hacker, Vanessa Redecke, et al.. (2004). Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene. 331. 159–164. 66 indexed citations

12.

Berger, Thomas, H. Schell, M. Simon, et al.. (2003). Two Unusual Cases of Diffuse Acrodermatitis Chronica Atrophicans Seronegative for Lyme Borreliosis. European Journal of Clinical Microbiology & Infectious Diseases. 22(6). 392–395. 6 indexed citations

13.

Humrich, Jens Y., et al.. (2003). Antigen loading of dendritic cells with whole tumor cell preparations. Journal of Immunological Methods. 277(1-2). 1–16. 62 indexed citations

14.

Strasser, Erwin, Thomas Berger, Volker Weisbach, et al.. (2003). Comparison of two apheresis systems for the collection of CD14+ cells intended to be used in dendritic cell culture. Transfusion. 43(9). 1309–1316. 18 indexed citations

15.

Yılmaz, Atilla, Christine Reiss, Alexander Weng, et al.. (2003). HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis. 172(1). 85–93. 117 indexed citations

16.

Schuler‐Thurner, Beatrice, Erwin Schultz, Thomas Berger, et al.. (2002). Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells. The Journal of Experimental Medicine. 195(10). 1279–1288. 391 indexed citations

17.

Viestenz, Arne, Thomas Berger, & Michael Küchle. (2002). Cutaneous melanoma metastasizing to the iris and choroid: a case report. Graefe s Archive for Clinical and Experimental Ophthalmology. 240(12). 1036–1038. 4 indexed citations

18.

Berger, Thomas, et al.. (2002). Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories™. Journal of Immunological Methods. 268(2). 131–140. 105 indexed citations

19.

Meinl, Edgar, Golo Henning, Christine Kuhnt, et al.. (2001). Signaling Lymphocytic Activation Molecule Is Expressed on Mature CD83+ Dendritic Cells and Is Up-Regulated by IL-1β. The Journal of Immunology. 167(4). 1989–1995. 94 indexed citations

20.

Berger, Thomas, Christian Maczek, Claudia Röder, et al.. (2000). A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. Journal of Immunological Methods. 245(1-2). 15–29. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact